12/7/2009 9:38:45 AM
SAN DIEGO--(BUSINESS WIRE)--Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today announced it has entered into a research collaboration agreement with the Boston University School of Medicine. The agreement focuses on advancing research in the roles of mitochondrial oxidative damage in degenerative, aging and metabolic diseases, such as anemia and diabetes. Boston University scientists will use Cyntellect’s award-winning LEAP™ Cell Processing Workstation to analyze, purify and process cells with great precision and simplicity within microplates, right where they are grown in the lab.
comments powered by